Gene Lee

Gene is the Founder, Chairman of the board of directors and visionary behind the Avellino Labs network of companies. A serial entrepreneur, he started Avellino Labs in 2008 in South Korea and brings more than 20 years of experience leading pharmaceutical, healthcare, and genetic diagnostics teams. In 2013, Gene relocated to Silicon Valley to support […]

Jon Robson

As Avellino’s President, CEO and member of the Board of Directors, Jon Robson brings to the company his experience in creating value from data and analytics with both early-stage technology companies and large multinational data businesses. He was the founder and CEO of MoneyLine Telerate, CEO of Reuters Americas, President of Thomson Reuters Enterprise Division, […]

Thomas Kim

Tom is Avellino’s Chief Strategy Officer and Corporate Secretary. Tom was Avellino Labs’ outside legal counsel from the incorporation of Avellino Labs USA office in 2011. He later became a consultant to the Board of Directors in 2015, then became a member of the Board of Directors of Avellino Labs in 2016, ultimately becoming the […]

Laiq Ahmad

Laiq Ahmad is Avellino’s Chief Technology Officer, bringing more than 22 years of experience to the role. Laiq has advanced knowledge of digital transformation, cloud technologies, big data, AI, and machine learning. He leads the technology, engineering and innovation engine for the company’s next-generation sequencing applications and platforms, drives technology breakthroughs, and supports Avellino’s growth […]

Cyril Allouche, MBA, CPA

Cyril Allouche is Avellino’s Chief Financial Officer and Treasurer. Mr. Allouche brings to Avellino over 20 years of experience in finance leadership in both public and pre-IPO companies, including diagnostics and biopharmaceutical. He most recently served as CFO at Dermavant Sciences and held finance leadership roles at Revance Therapeuthics and CareDx. He also spent over […]

Nazneen Aziz, PhD

Dr. Aziz joins us after an impressive career at renowned health care institutions and educational centers such as Kaiser Permanente, the College of American Pathologists, Harvard Medical School/Boston Children’s Hospital, and Tufts University. She received her degrees from Wellesley and MIT, and has received multiple awards from MIT, National Institutes of Health, National Kidney Foundation, […]

Eric Bernabei

Eric joins Avellino Labs from Alcon, bringing 20 years of product development and commercialization experience in the ophthalmic surgical industry. Eric started his career in patient care and moved into industry in 1999 with Summit Technology, one of the first excimer laser manufacturers. He continued to develop and take commercial leadership positions within Summit, BD […]

Joe Boyd

Joe joins Avellino from Novartis, where he led the Market Development organization to record growth for their dry-eye product, Xiidra. Joe has over 25 years of experience and played key roles in large, mid-size, and start-up companies in the diagnostic, pharmaceutical and medical device industries. Prior to Novartis, Joe successfully built and led teams at […]

Genya Dana, Ph.D.

Dr. Genya Dana joins Avellino from the World Economic Forum, where she spent five years building partnerships to catalyse sustainable and innovative uptake of new technologies, financial models, delivery approaches and treatment options to affect health and well-being globally. Genya brings a unique blend of policy, diplomatic and technical skills to the role of Global […]

John Hong

John brings over 12 years of HR, employment, and labor law experience to Avellino. John’s roles at Avellino include the development of HR/business/privacy/legal policies and processes, training, people/workforce development, business strategies, workforce plans, talent acquisition, and programs that align with the organization’s overall strategic growth. Prior to joining Avellino, John was a shareholder at the […]

Scott Korney

Scott Korney joined Avellino in 2012 and holds the distinction as the company’s first US employee. He has led several different areas of the company, including as Chief Operating Officer (2012 – 2020); Head of U.S. Operations (2021); and currently serves as Global Head of Facilities and Real Estate. His talents and dedication have helped […]